ALPS
Alps Group Inc
NASDAQ · Healthcare · Biotechnology · MY
$0.37
−2.63%Margins
Gross margin
38.6%
EBITDA margin
-1985.6%
EBIT margin
-1983.1%
Net margin
-2004.5%
FCF margin
-50.2%
601.8%
Return on equity
-3884.2%
Return on assets
1257.9%
Return on invested capital
1.22x
Asset turnover
-$1.6M
Cash from operations
$0.00
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2025